51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC)
Saved in:
| Title: | 51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC) |
|---|---|
| Authors: | Mantovani, G., Massa, E., Madeddu, C., Gramignano, G., Astara, G., Lusso, M., Cherchi, V., Serpe, R. |
| Source: | Lung Cancer (01695002). Jul2005 Supplement 2, Vol. 49, pS392-S392. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
